Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.41 |
| ▸ | MEN1 | O00255 | 7/20 | 0.41 |
| ▸ | MAPT | P10636 | 7/20 | 0.41 |
| ▸ | HPGD | P15428 | 7/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15887853 | 0.97 | KDM4E (0.46) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL15887867 | 0.96 | KDM4E (0.43) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL25526561 | 0.96 | KMT2A (0.40) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL6375110 | 0.96 | KDM4E (0.45) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL17228035 | 0.96 | KDM4E (0.45) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL15394857 | 0.96 | KDM4E (0.45) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL14748981 | 0.96 | KMT2A (0.42) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL15394941 | 0.96 | KDM4E (0.45) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL6375043 | 0.96 | KMT2A (0.42) | KDM4EL3MBTL1ATMKMT2AMEN1 | |
| SCHEMBL21973901 | 0.96 | KDM4E (0.47) | KDM4EL3MBTL1ATMKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785003-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | IDEMTISU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785003-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | IDEMTISU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20110291081-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-01 | — | — | US | disclosed |
| US-20110291081-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110291081-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | ELAVL1, ELAVL3, OR10J3 | KDM4E 351/4885L3MBTL1 295/4885ATM 3795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.